| __timestamp | ImmunityBio, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 4101058 |
| Thursday, January 1, 2015 | 11434000 | 10763215 |
| Friday, January 1, 2016 | 26546000 | 5579049 |
| Sunday, January 1, 2017 | 39778000 | 32051299 |
| Monday, January 1, 2018 | 53418000 | 24482286 |
| Tuesday, January 1, 2019 | 111997000 | 43892589 |
| Wednesday, January 1, 2020 | 139507000 | 44505000 |
| Friday, January 1, 2021 | 195958000 | 79406000 |
| Saturday, January 1, 2022 | 248149000 | 49283000 |
| Sunday, January 1, 2023 | 232366000 | 17282730 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, ImmunityBio, Inc. and Verona Pharma plc have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, ImmunityBio's R&D expenses surged by over 14,500%, peaking in 2022, reflecting a robust focus on pioneering advancements. In contrast, Verona Pharma's R&D spending, while more modest, increased by approximately 320% during the same period, with a notable peak in 2021. This disparity highlights ImmunityBio's aggressive strategy in the competitive biotech landscape, while Verona Pharma adopts a more measured approach. As the industry continues to grow, these spending patterns offer valuable insights into each company's strategic priorities and potential future breakthroughs.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Verona Pharma plc vs Dynavax Technologies Corporation
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited